Immunosuppressants - Iraq

Iraq

In Iraq, the Immunosuppressants market is anticipated to witness a significant increase in revenue, with projections indicating a staggering amount of US$42.20m in 2024.
This growth is expected to continue at an annual growth rate of 15.46%, leading to a market volume of US$86.58m by 2029.
When compared globally, it is worth noting that United States will generate the highest revenue in this market, with an estimated amount of US$35,470.00m in 2024.
Despite the challenges faced by Iraq's healthcare system, the demand for immunosuppressants remains high due to the prevalence of conditions requiring organ transplantation.

Key regions: Australia, Germany, United Kingdom, United States, France

Market

Region

Region comparison

Currency

Analyst Opinion

Iraq, a country in the Middle East, has experienced significant development in the healthcare sector over the past few years. The Immunosuppressants market in Iraq has also witnessed growth due to several factors.

Customer preferences: In Iraq, the demand for Immunosuppressants has increased due to the rising prevalence of autoimmune diseases and organ transplants. Patients suffering from autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease require Immunosuppressants to reduce inflammation and prevent damage to their organs. Similarly, patients who undergo organ transplants require Immunosuppressants to prevent the rejection of the transplanted organ.

Trends in the market: The Immunosuppressants market in Iraq has witnessed a shift towards generic drugs due to the high cost of branded Immunosuppressants. The government has also taken measures to promote the use of generic drugs by reducing the prices of generic Immunosuppressants. This has led to an increase in the availability of Immunosuppressants in the market and has made them more affordable for patients.

Local special circumstances: The political instability in Iraq has affected the healthcare sector, and the Immunosuppressants market is no exception. The ongoing conflicts in the country have led to a shortage of medical supplies, including Immunosuppressants. This has made it difficult for patients to access the medication they need, and in some cases, has led to the use of counterfeit drugs.

Underlying macroeconomic factors: The Iraqi economy heavily relies on oil exports, and the fluctuations in oil prices have a significant impact on the country's economy. The decrease in oil prices in recent years has led to a decrease in government spending on healthcare, including the procurement of Immunosuppressants. This has affected the availability of Immunosuppressants in the market and has led to an increase in their prices.In conclusion, the Immunosuppressants market in Iraq has witnessed growth due to the rising prevalence of autoimmune diseases and organ transplants. The shift towards generic drugs has made Immunosuppressants more affordable for patients. However, the ongoing conflicts in the country have affected the healthcare sector, leading to a shortage of medical supplies, including Immunosuppressants. The decrease in government spending on healthcare due to the fluctuations in oil prices has also affected the availability and affordability of Immunosuppressants in the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.